Kyntra Bio Statistics
NASDAQ: KYNBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.16+0.115 (+1.90%)
Market open · Delayed 15 min · as of Oct 8, 11:25 AM ET
Kyntra Bio by the numbers
Kyntra Bio has a market capitalization of $24.9 million based on 4.05M shares outstanding. With trailing EPS of $-7.64, Kyntra Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.6% below its 50-day average and 17.1% below its 200-day average.
Average daily trading volume is 18.32K shares, or about $112,766 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KYNB valuation vs. peer median
| Metric | KYNB | Peer median | Difference |
|---|---|---|---|
| Market cap | $24.92M | $24.80M | +0% |
| Avg. volume | 18.32K | 68.08K | -73% |
Peer median across 8 companies: SHPH, ATOS, BYSI, ABVC, TXMD, OPTH, MCRB, AYTU.
Valuation
- Market cap
- $24.92M
- EPS (TTM)
- $-7.64
- Shares outstanding
- 4.05M
Price and trading
- Previous close
- 6.04
- Open
- 6.07
- Day range
- 6.07 – 6.16
- 52-week range
- 5.62 – 11.65
- 52-week change
- -44.63%
- Beta
- —
- Volume
- 7.44K
- Average volume
- 18.32K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 24.92M
- Forward Pe
- -0.43
- Eps
- -7.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.65
- Week52 Low
- 5.62
- Avg Volume
- 18,321.00
- Shares Outstanding
- 4.05M
- Ma50
- 7.29
- Ma200
- 7.42
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -47.17%
- Pct From52w Low
- 9.52%